Lack of evidence for cross-competition between vasoactive intestinal peptide and somatostatin at their respective receptors

Author： Hannon J.P.   Langenegger D.   Waser B.   Hoyer D.   Reubi J.-C.  

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.426, Iss.3, 2001-08, pp. : 165-173

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Role of G protein-coupled vasoactive intestinal peptide receptors in HIV integration

By Branch Donald R  

Future Virology, Vol. 6, Iss. 6, 2011-06 ,pp. : 741-753

Future Medicine

Access to resources Recommend Favorite

Vasoactive Intestinal Peptide Receptors: A Molecular Target in Breast and Lung Cancer

By  

Current Pharmaceutical Design, Vol. 13, Iss. 11, 2007-04 ,pp. : 1099-1104

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Potential of Vasoactive Intestinal Peptide and its Receptors in Neurological Disorders

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 9, Iss. 5, 2010-11 ,pp. : 661-666

Bentham Science Publishers

Access to resources Recommend Favorite

Distinct receptors mediate pituitary adenylate cyclase-activating peptide- and vasoactive intestinal peptide-induced relaxation of rat ileal longitudinal muscle

By Ekblad E.   Sundler F.  

European Journal of Pharmacology, Vol. 334, Iss. 1, 1997-09 ,pp. : 61-66

Elsevier

Access to resources Recommend Favorite

Vasoactive intestinal peptide modification at position 22 allows discrimination between receptor subtypes

By Gourlet P.   Vandermeers-Piret M.-C.   Rathe J.   De Neef P.   Cnudde J.   Robberecht P.   Waelbroeck M.  

European Journal of Pharmacology, Vol. 348, Iss. 1, 1998-05 ,pp. : 95-99

Elsevier

Access to resources Recommend Favorite